메뉴 건너뛰기




Volumn 14, Issue 1, 2013, Pages 51-55

Effects of low-dose pioglitazone on glucose control, lipid profiles, renin-angiotensin-aldosterone system and natriuretic peptides in diabetic patients with coronary artery disease

Author keywords

coronary artery disease; diabetes; natriuretic peptide; Pioglitazone; renin angiotensin aldosterone

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NATRIURETIC FACTOR; PIOGLITAZONE; RENIN; TRIACYLGLYCEROL;

EID: 84874032277     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312452028     Document Type: Article
Times cited : (8)

References (19)
  • 1
    • 0037382455 scopus 로고    scopus 로고
    • Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus
    • Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc. 2003 ; 78: 447-456
    • (2003) Mayo Clin Proc , vol.78 , pp. 447-456
    • Gerich, J.E.1
  • 2
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 ; 358: 2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 3
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 ; 358: 2560-2572
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 4
    • 0036072223 scopus 로고    scopus 로고
    • Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients
    • Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002 ; 87: 2784-2791
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 2784-2791
    • Miyazaki, Y.1    Mahankali, A.2    Matsuda, M.3
  • 5
    • 10744225126 scopus 로고    scopus 로고
    • Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect
    • Satoh N, Ogawa Y, Usui T, et al. Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect. Diabetes Care. 2003 ; 26: 2493-2499
    • (2003) Diabetes Care , vol.26 , pp. 2493-2499
    • Satoh, N.1    Ogawa, Y.2    Usui, T.3
  • 6
    • 34250347668 scopus 로고    scopus 로고
    • Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: A meta-analysis of randomized controlled trials
    • Rosmarakis ES, Falagas ME. Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J. 2007 ; 154: 14-50
    • (2007) Am Heart J , vol.154 , pp. 14-50
    • Rosmarakis, E.S.1    Falagas, M.E.2
  • 7
    • 26244453309 scopus 로고    scopus 로고
    • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomized controlled trial
    • Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet. 2005 ; 366: 1279-1289
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.3
  • 8
    • 41649084422 scopus 로고    scopus 로고
    • Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The PERISCOPE randomized controlled trial
    • Nissen SE, Nicholls SJ, Wolski K, et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA. 2008 ; 299: 1561-1573
    • (2008) JAMA , vol.299 , pp. 1561-1573
    • Nissen, S.E.1    Nicholls, S.J.2    Wolski, K.3
  • 9
    • 73749087583 scopus 로고    scopus 로고
    • Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound
    • Nakayama T, Komiyama N, Yokoyama M, et al. Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: a randomized prospective study using intravascular ultrasound. Int J Cardiol. 2010 ; 138: 157-165
    • (2010) Int J Cardiol , vol.138 , pp. 157-165
    • Nakayama, T.1    Komiyama, N.2    Yokoyama, M.3
  • 10
    • 22644438570 scopus 로고    scopus 로고
    • Pioglitazone initiation and subsequent hospitalization for congestive heart failure
    • Karter AJ, Ahmed AT, Liu H, et al. Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med. 2005 ; 22: 986-993
    • (2005) Diabet Med , vol.22 , pp. 986-993
    • Karter, A.J.1    Ahmed, A.T.2    Liu, H.3
  • 11
    • 0042383369 scopus 로고    scopus 로고
    • Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone
    • Ogawa S, Takeuchi K, Ito S. Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone. J Clin Endocrinol Metab. 2003 ; 88: 3993-3996
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3993-3996
    • Ogawa, S.1    Takeuchi, K.2    Ito, S.3
  • 12
    • 22344445087 scopus 로고    scopus 로고
    • Relationship between plasma hANP level and pretibial edema by pioglitazone treatment
    • Kahara T, Takamura T, Misaki T, et al. Relationship between plasma hANP level and pretibial edema by pioglitazone treatment. Endocrine J. 2005 ; 52: 373-376
    • (2005) Endocrine J , vol.52 , pp. 373-376
    • Kahara, T.1    Takamura, T.2    Misaki, T.3
  • 13
    • 39049116452 scopus 로고    scopus 로고
    • Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes
    • Sambanis C, Tziomalos K, Kountana E, et al. Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes. Acta Diabetol. 2008 ; 45: 23-30
    • (2008) Acta Diabetol , vol.45 , pp. 23-30
    • Sambanis, C.1    Tziomalos, K.2    Kountana, E.3
  • 14
    • 1542652476 scopus 로고    scopus 로고
    • Thiazolidines, peripheral edema, and type 2 diabetes: Incidence, pathophysiology, and clinical implications
    • Mudaliar S, Chang AR, Henry RR. Thiazolidines, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract. 2003 ; 9: 406-416
    • (2003) Endocr Pract , vol.9 , pp. 406-416
    • Mudaliar, S.1    Chang, A.R.2    Henry, R.R.3
  • 15
    • 0346219290 scopus 로고    scopus 로고
    • Considerations for management of fluid dynamic issues associated with thiazolidinediones
    • Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med. 2003 ; 115: 111S - 115S
    • (2003) Am J Med , vol.115
    • Hollenberg, N.K.1
  • 16
    • 0035668546 scopus 로고    scopus 로고
    • The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein- depleted plasma (FER(HDL))
    • Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001 ; 34: 583-588
    • (2001) Clin Biochem , vol.34 , pp. 583-588
    • Dobiasova, M.1    Frohlich, J.2
  • 17
    • 79953193064 scopus 로고    scopus 로고
    • Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
    • Dobiasova M, Frohlich J, Sedova M, et al. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011 ; 52: 566-571
    • (2011) J Lipid Res , vol.52 , pp. 566-571
    • Dobiasova, M.1    Frohlich, J.2    Sedova, M.3
  • 18
    • 0028340551 scopus 로고
    • Stability of human atrial natriuretic peptide in blood samples
    • Tsuji T, Masuda H, Imagawa K, et al. Stability of human atrial natriuretic peptide in blood samples. Clin Chim Acta. 1994 ; 225: 171-177
    • (1994) Clin Chim Acta , vol.225 , pp. 171-177
    • Tsuji, T.1    Masuda, H.2    Imagawa, K.3
  • 19
    • 1642302410 scopus 로고    scopus 로고
    • Effects of the peroxisomal proliferator-activated receptor-γ agonist pioglitazone on renal and hormonal responses to salt in healthy men
    • Zanchi A, Chiolero A, Maillard M, et al. Effects of the peroxisomal proliferator-activated receptor-γ agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab. 2004 ; 89: 1140-1145
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1140-1145
    • Zanchi, A.1    Chiolero, A.2    Maillard, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.